When one is preparing cells for the 10x genomics single cell RNA Seq platform, the manual says to dilute the cells (in media or 1x PBS) into water for a final volume of 46.6ul to achieve your targeted cell recovery. Do users mix their cell suspension in with water, then pipette into the mastermix at this step?
-
-
In the 3' v2 protocol, 10x recommended making your mastermix, then adding water to the mastermix and pipette mixing, and then finally adding your cells to the mastermix with water.
The newest 3' v3 protocol, they do not specify an order at that step, but I have been doing it in the same order as the v2 without issue. -
Thanks Joe. It seems very confusing that they would have written so clearly in the v2 manual but this critical description is removed from the v3 manual! I wonder who made such a terrible decision to remove it. Those who pick up the v3 manual and not know of v2 would not be able to see through this. If that is the order required, it should be given in both manuals.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment